The P-selectin gene polymorphism val168Met: A novel risk marker for the occurrence of primary ventricular fibrillation during acute myocardial infarction

Journal of Cardiovascular Electrophysiology

Volumn 21, Issue 11, 2010, Pages 1260-1265

  Elmas, Elif ^a   Bugert, Peter ^b   Popp, Tatjana ^a   Lang, Siegfried ^a   Weiss, Christel ^a   Behnes, Michael ^a   Borggrefe, Martin ^a   Kälsch, Thorsten ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Institute of Transfusion Medicine and Immunology   (Germany)

Author keywords

Myocardial infarction; P selectin polymorphisms; Sudden cardiac death; Ventricular fibrillation

Indexed keywords

BIOLOGICAL MARKER; CD40 LIGAND; METHIONINE; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; SODIUM CHANNEL NAV1.5; VALINE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEART VENTRICLE FIBRILLATION; HEREDITY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SUDDEN DEATH; TANDEM REPEAT; THROMBOCYTE ADHESION; VARIABLE NUMBER OF TANDEM REPEAT;

COMORBIDITY; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; P-SELECTIN; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; VENTRICULAR FIBRILLATION;

EID: 78349274094     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2010.01833.x     Document Type: Article

References (38)

1. Spooner PM,: The larger problem the larger genome. J Cardiovasc Electrophysiol 2009; 20: 585 -596.
2. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC Jr, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL,: ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006; 48: e247 -e346.
3. Spooner PM, Albert C, Benjamin EJ, Boineau R, Elston RC, George AL Jr, Jouven X, Kuller LH, MacCluer JW, Marban E, Muller JE, Schwartz PJ, Siscovick DS, Tracy RP, Zareba W, Zipes DP,: Sudden cardiac death, genes, and arrhythmogenesis: Consideration of new population and mechanistic approaches from a National Heart, Lung, and Blood Institute workshop, Part II. Circulation 2001; 103: 2447 -2452. (Pubitemid 32493370)
4. Spooner PM, Albert C, Benjamin EJ, Boineau R, Elston RC, George AL Jr, Jouven X, Kuller LH, MacCluer JW, Marban E, Muller JE, Schwartz PJ, Siscovick DS, Tracy RP, Zareba W, Zipes DP,: Sudden cardiac death, genes, and arrhythmogenesis: Consideration of new population and mechanistic approaches from a National Heart, Lung, and Blood Institute workshop, part I. Circulation 2001; 103: 2361 -2364. (Pubitemid 32448800)
5. Kragel AH, Gertz SD, Roberts WC,: Morphologic comparison of frequency and types of acute lesions in the major epicardial coronary arteries in unstable angina pectoris, sudden coronary death and acute myocardial infarction. J Am Coll Cardiol 1991; 18: 801 -808.
6. Kalsch T, Elmas E, Nguyen XD, Wolpert C, Kluter H, Borggrefe M, Haase KK, Dempfle CE,: Enhanced expression of platelet CD40-ligand by in vitro lipopolysaccharide-challenge in patients with ventricular fibrillation complicating acute myocardial infarction. Int J Cardiol 2006; 107: 350 -355.
7. Elmas E, Kaelsch T, Wolpert C, Sueselbeck T, Bertsch T, Dempfle CE, Borggrefe M,: Assessment of markers of thrombin generation in patients with acute myocardial infarction complicated by ventricular fibrillation. Clin Cardiol 2006; 29: 165 -169.
8. Goldstein JA, Butterfield MC, Ohnishi Y, Shelton TJ, Corr PB,: Arrhythmogenic influence of intracoronary thrombosis during acute myocardial ischemia. Circulation 1994; 90: 139 -147.
9. Kowey PR, Verrier RL, Lown B, Handin RI,: Influence of intracoronary platelet aggregation on ventricular electrical properties during partial coronary artery stenosis. Am J Cardiol 1983; 51: 596 -602.
10. Park TH, McHowat J, Wolf RA, Corr PB,: Increased lysophosphatidylcholine content induced by thrombin receptor stimulation in adult rabbit cardiac ventricular myocytes. Cardiovasc Res 1994; 28: 1263 -1268.
11. Merten M, Chow T, Hellums JD, Thiagarajan P,: A new role for P-selectin in shear-induced platelet aggregation. Circulation 2000; 102: 2045 -2050.
12. Lip GY, Blann AD, Zarifis J, Beevers M, Lip PL, Beevers DG,: Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: Implications for atherogenesis? A preliminary report. J Hypertens 1995; 13: 1674 -1678.
13. Herrmann SM, Ricard S, Nicaud V, Mallet C, Evans A, Ruidavets JB, Arveiler D, Luc G, Cambien F,: The P-selectin gene is highly polymorphic: Reduced frequency of the Pro715 allele carriers in patients with myocardial infarction. Hum Mol Genet 1998; 7: 1277 -1284.
14. Tregouet DA, Barbaux S, Escolano S,: Specific haplotypes of the P-selectin gene are associated with myocardial infarction. Hum Mol Genet 2002; 11: 2015 -2023.
15. Bugert P, Vosberg M, Entelmann M, Jahn J, Katus HA, Kluter H,: Polymorphisms in the P-selectin (CD62P) and P-selectin glycoprotein ligand-1 (PSGL-1) genes and coronary heart disease. Clin Chem Lab Med 2004; 42: 997 -1004.
16. Kee F, Morrison C, Evans AE, McCrum E, McMaster D, Dallongeville J, Nicaud V, Poirier O, Cambien F,: Polymorphisms of the P-selectin gene and risk of myocardial infarction in men and women in the ECTIM extension study. Etude cas-temoin de linfarctus myocarde. Heart 2000; 84: 548 -552.
17. Barbaux SC, Blankenberg S, Rupprecht HJ, Francomme C, Bickel C, Hafner G, Nicaud V, Meyer J, Cambien F, Tiret L,: Association between P-selectin gene polymorphisms and soluble P-selectin levels and their relation to coronary artery disease. Arterioscler Thromb Vasc Biol 2001; 21: 1668 -1673.
18. Afshar-Kharghan V, Diz-Kucukkaya R, Ludwig EH, Marian AJ, Lopez JA,: Human polymorphism of P-selectin glycoprotein ligand 1 attributable to variable numbers of tandem decameric repeats in the mucinlike region. Blood 2001; 97: 3306 -3307.
19. Lozano ML, Gonzalez-Conejero R, Corral J, Rivera J, Iniesta JA, Martinez C, Vicente V,: Polymorphisms of P-selectin glycoprotein ligand-1 are associated with neutrophil-platelet adhesion and with ischaemic cerebrovascular disease. Br J Haematol 2001; 115: 969 -976.
20. Tregouet DA, Barbaux S, Poirier O, Blankenberg S, Bickel C, Escolano S, Rupprecht HJ, Meyer J, Cambien F, Tiret L,: SELPLG gene polymorphisms in relation to plasma SELPLG levels and coronary artery disease. Ann Hum Genet 2003; 67: 504 -511. (Pubitemid 38016711)
21. Ackerman MJ, Splawski I, Makielski JC, Tester DJ, Will ML, Timothy KW, Keating MT, Jones G, Chadha M, Burrow CR, Stephens JC, Xu C, Judson R, Curran ME,: Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: Implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing. Heart Rhythm 2004; 1: 600 -607.
22. Benjamin EJ, Rice KM, Arking DE, Pfeufer A, Van Noord C, Smith AV, Schnabel RB, Bis JC, Boerwinkle E, Sinner MF, Dehghan A, Lubitz SA, D'Agostino RB Sr, Lumley T, Ehret GB, Heeringa J, Aspelund T, Newton-Cheh C, Larson MG, Marciante KD, Soliman EZ, Rivadeneira F, Wang TJ, Eirksdottir G, Levy D, Psaty BM, Li M, Chamberlain AM, Hofman A, Vasan RS, Harris TB, Rotter JI, Kao WH, Agarwal SK, Stricker BH, Wang K, Launer LJ, Smith NL, Chakravarti A, Uitterlinden AG, Wolf PA, Sotoodehnia N, Köttgen A, Van Duijin CM, Meitinger T, Mueller M, Perz S, Steinbeck G, Wichmann HE, Lunetta KL, Heckbert SR, Gudnason V, Alonso A, Kb S, Ellinor PT, Witteman JC,: Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat Genet 2009; 41: 879 -881.
23. Bugert P, Hoffmann MM, Winkelmann BR, Vosberg M, Jahn J, Entelmann M, Katus HA, Marz W, Mansmann U, Boehm BO, Goerg S, Kluter H,: The variable number of tandem repeat polymorphism in the P-selectin glycoprotein ligand-1 gene is not associated with coronary heart disease. J Mol Med 2003; 81: 495 -501.
24. Bugert P, Pabinger I, Stamer K, Vormittag R, Skeate RC, Wahi MM, Panzer S,: The risk for thromboembolic disease in lupus anticoagulant patients due to pathways involving P-selectin and CD154. Thromb Haemost 2007; 97: 573 -580.
25. Viswanathan PC, Benson DW, Balser JR,: A common SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation. J Clin Invest 2003; 111: 341 -346.
26. Revelle BM, Scott D, Beck PJ,: Single amino acid residues in the E-and P-selectin epidermal growth factor domains can determine carbohydrate binding specificity. J Biol Chem 1996; 271: 16160 -16170.
27. Lim HS, Blann AD, Lip GY,: Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: Relationships to cardiovascular disease and risk factor intervention. Circulation 2004; 109: 2524 -2528.
28. Blann AD, Faragher EB, McCollum CN,: Increased soluble P-selectin following myocardial infarction: A new marker for the progression of atherosclerosis. Blood Coagul Fibrinolysis 1997; 8: 383 -390.
29. Ikeda H, Nakayama H, Oda T, Kuwano K, Muraishi A, Sugi K, Koga Y, Toshima H,: Soluble form of P-selectin in patients with acute myocardial infarction. Coron Artery Dis 1994; 5: 515 -518.
30. Johnson-Tidey RR, McGregor JL, Taylor PR, Poston RN,: Increase in the adhesion molecule P-selectin in endothelium overlying atherosclerotic plaques. Coexpression with intercellular adhesion molecule-1. Am J Pathol 1994; 144: 952 -961.
31. Blann AD, Dobrotova M, Kubisz P, McCollum CN,: Von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis. Thromb Haemost 1995; 74: 626 -630.
32. Morrison AC, Bare LA, Chambless LE, Ellis SG, Malloy M, Kane JP, Pankow JS, Devlin JJ, Willerson JT, Boerwinkle E,: Prediction of coronary heart disease risk using a genetic risk score: The Atherosclerosis Risk in Communities Study. Am J Epidemiol 2007; 166: 28 -35.
33. Ridker PM, Buring JE, Rifai N,: Soluble P-selectin and the risk of future cardiovascular events. Circulation 2001; 103: 491 -495.
34. Trowbridge EA, Slater DN, Kishk YT, Woodcock BW, Martin JF,: Platelet production in myocardial infarction and sudden cardiac death. Thromb Haemost 1984; 52: 167 -171.
35. Elmas E, Lang S, Dempfle CE, Kalsch T, Hannak D, Sueselbeck T, Wolpert C, Borggrefe M, Brueckmann M,: High plasma levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) and interleukin-8 (IL-8) characterize patients prone to ventricular fibrillation complicating myocardial infarction. Clin Chem Lab Med 2007; 45: 1360 -1365.
36. Elmas E, Holzer L, Lang S, Popp T, Kalsch T, Wolpert C, Brueckmann M, Borggrefe M,: Enhanced proinflammatory response of mononuclear cells to in vitro LPS-challenge in patients with ventricular fibrillation in the setting of acute myocardial infarction. Cytokine 2008; 43: 138 -142.
37. Haerem JW,: Platelet aggregates in intramyocardial vessels of patients dying suddenly and unexpectedly of coronary artery disease. Atherosclerosis 1972; 15: 199 -213.
38. Falk E,: Unstable angina with fatal outcome: Dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation 1985; 71: 699 -708.